TrademarkDir
MYROBALAN THERAPEUTICS
LIVE

Serial Number

97111174

Owner

Myro Therapeutics

Attorney

John L. DuPre'

Filing Date

Nov 5, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

MYROBALAN THERAPEUTICS Trademark

Serial Number: 97111174

MYROBALAN THERAPEUTICS is a trademark filed by Myro Therapeutics on November 5, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Myro Therapeutics (2 trademarks)

1337 Massachusetts Ave. #282
Arlington, MA 02476

Entity Type: 03

Trademark Details

Filing Date

November 5, 2021

Registration Date

Not Registered

Published for Opposition

January 9, 2024

Goods & Services

research and development of pharmaceutical preparations not derived from or containing a component of the myrobalan tree

pharmaceutical preparations for the treatment of neurodegenerative diseases, demyelination diseases, schizophrenia spectrum disorders, neuropathic pain, neuroinflammation diseases, neuroexcitation disorders, immunological disorders and cancers, the pharmaceutical preparations are not derived from or containing a component of the myrobalan tree

Filing History

SOU TEAS EXTENSION RECEIVED
Aug 7, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 4, 2026 EXRA
SOU EXTENSION 4 GRANTED
Feb 3, 2026 EX4G
SOU EXTENSION 4 FILED
Feb 3, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 3, 2026 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 18, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 18, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 18, 2025 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jul 2, 2025 EX3G
SOU EXTENSION 3 FILED
Jul 2, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 2, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 9, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jan 9, 2025 EX2G
SOU EXTENSION 2 FILED
Jan 9, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 9, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 9, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jul 9, 2024 EX1G
SOU EXTENSION 1 FILED
Jul 9, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 9, 2024 EEXT
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 16, 2024 ASCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 5, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 20, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 30, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 10, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 10, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 10, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 10, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 10, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 10, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 10, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 16, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 16, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 1, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 1, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 1, 2023 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 16, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 16, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 16, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 16, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 17, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2021 NWOS
NEW APPLICATION ENTERED
Nov 9, 2021 NWAP

Related Trademarks

More from this Owner

MYROBALAN THERAPEUTICS

MYROBALAN THERAPEUTICS

MYROBALAN THERAPEUTICS

MYROBALAN THERAPEUTICS